Most drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.
from Healthy Aging News -- ScienceDaily https://ift.tt/NPB7TeR
No comments:
Post a Comment